{{Rsnum
|rsid=11045819
|Gene=SLCO1B1
|Chromosome=12
|position=21176879
|Orientation=plus
|GMAF=0.07851
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=SLCO1B1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 3.5 | 31.0 | 65.5
| HCB | 0.0 | 2.2 | 97.8
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.7 | 12.2 | 87.1
| ASW | 0.0 | 16.1 | 83.9
| CHB | 0.0 | 2.2 | 97.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 10.0 | 90.0
| LWK | 0.0 | 4.5 | 95.5
| MEX | 0.0 | 12.1 | 87.9
| MKK | 0.0 | 4.5 | 95.5
| TSI | 0.0 | 27.7 | 72.3
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11045819
|Name_s=SLCO1B1:463C>A, SLCO1B1:*4
|Gene_s=SLCO1B1
|Feature=Exon/NonSyn
|Evidence=PubMed ID:18781850
|Annotation=Subjects homozygous for this genotype showed decreased response to fluvastatin
|Drugs=fluvastatin
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA164891480
}}

{{PMID Auto
|PMID=20139798
|Title=ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
}}

{{PMID Auto
|PMID=20973885
|Title=Organic anion transporter 1B1 (SLCO1B1) polymorphism and gallstone formation: High incidence of Exon4 CA genotype in female patients in North India.
}}

{{PMID Auto
|PMID=22136368
|Title=Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
}}

{{GET Evidence
|gene=SLCO1B1
|aa_change=Pro155Thr
|aa_change_short=P155T
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11045819
|overall_frequency_n=1451
|overall_frequency_d=10732
|overall_frequency=0.135203
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=1
|n_articles_annotated=1
|qualityscore_in_silico=2
|qualitycomment_in_silico=Y
|in_pharmgkb=Y
|nblosum100=4
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23100282
|Title=Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
|OA=1
}}

{{PMID Auto
|PMID=23133420
|Title=Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}